H19 and breast cancer: Zhang et al. used the same method to determine differentiated H19 lncRNA expression in cancer tissues and then tested their expression in serum samples from both 96 healthy (control) and 102 breast cancer patients and found their significantly higher expression (P < 0.05); its ACC is 0.81, which is higher than CEA and CA153 [31].